Breast cancer screening rates are declining,according to a recent study by the Centers forDisease Control and Prevention.
Breast cancer screening rates are declining, according to a recent study by the Centers for Disease Control and Prevention.
CDC researchers analyzed mammography screening utilization for each U.S. state and correlated that with the state's respective breast cancer incidence rate. Although they saw a breast cancer incidence rate reduction from 2000 to 2006, investigators also found a slight decline in mammo use in two-thirds of the states during the same period. Findings were published in the February issue of the American Journal of Roentgenology. A commentary by radiologist Dr. Ruth C. Carlos warned that the trend could lead to the erosion of screening services and preventive care.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.